Tetrandrine
Spezifikationen
518-34-3CAS-Nummer
683-095-7EG-Nummer
(1S,14S)-9,20,21,25-tetramethoxy-15,30-dimethyl-7,23-dioxa-15,30-diazaheptacyclo[22.6.2.23,6.18,12.114,18.027,31.022,33]hexatriaconta-3(36),4,6(35),8,10,12(34),18,20,22(33),24,26,31-dodecaeneIUPAC-Name
C38H42N2O6Chemische Formel
622.7 g/molMolekulargewicht
tetrandrine; 518-34-3; D-Tetrandrine; (+)-Tetrandrine; Tetrandrin; Fanchinine; Sinomenine A; (S,S)-Tetrandrine; hanjisong; NSC-77037; NSC77037; 29EX23D5AJ; TETRANDRINE, D-; TETRANDRINE, (+)-; (1beta)-6,6',7,12-Tetramethoxy-2,2'-dimethylberbaman; (1S,14S)-9,20,21,25-tetramethoxy-15,30-dimethyl-7,23-dioxa-15,30-diazaheptacyclo[22.6.2.23,6.18,12.114,18.027,31.022,33]hexatriaconta-3(36),4,6(35),8,10,12(34),18,20,22(33),24,26,31-dodecaene; (1S,14S)-9,20,21,25-tetramethoxy-15,30-dimethyl-7,23-dioxa-15,30-diazaheptacyclo(22.6.2.23,6.18,12.114,18.027,31.022,33)hexatriaconta-3(36),4,6(35),8,10,12(34),18,20,22(33),24,26,31-dodecaene; RefChem:932847; tetrandrine, (1'beta)-; tetrandrine dihydrochloride, (1beta)-; 6,6',7,12-tetramethoxy-2,2'-dimethyl-(1beta)-berbaman; Berbaman, 6, 6',7,12-trtramethoxy-2,2'-dimethyl-, (1beta)-(PM)-; 683-095-7; (1S,14R)-9,20,21,25-tetramethoxy-15,30-dimethyl-7,23-dioxa-15,30-diazaheptacyclo(22.6.2.23,6.18,12.114,18.027,31.022,33)hexatriaconta-3(36),4,6(35),8,10,12(34),18,20,22(33),24,26,31-dodecaene; DL-Tetrandine; (S,S)-(+)-Tetrandrine; NSC 77037; (+-)-Tetrandine; Hanfangchin A; 23495-89-8; dl-Tetrandrine; S,S-(+)-Tetrandrine; FANCHININ; (+/-)-Tetrandine; (11S,31S)-16,36,37,54-tetramethoxy-12,32-dimethyl-11,12,13,14,31,32,33,34-octahydro-2,6-dioxa-1(7,1),3(8,1)-diisoquinolina-5(1,3),7(1,4)-dibenzenacyclooctaphane; (+/-)-Tetrandrine; NSC91771; MFCD08689909; Tetrandrine, (+/-)-; CHEBI:49; VS4W77H3SD; MLS002153946; NSC-91771; C38H42N2O6; SMR000445630; Berbaman, 6,6',7,12-tetramethoxy-2,2'-dimethyl-, (1beta)-; (4aS,16aS)-3,4,4a,5,16a,17,18,19-Octahydro-12,21,22,26-tetramethoxy-4,17-dimethyl-16H-1,24:6,9-dietheno-11,15-metheno-2H-pyrido[2',3':17,18][1,11]dioxacycloeicosino[2,3,4-ij]isoquinoline; (1.beta.)-6,6',7,12-Tetramethoxy-2,2'-dimethylberbaman; CCRIS 2705; tetramethoxy(dimethyl)[?]; NSC-77037;d-Tetrandrine; SR-01000779899; TETRANDRINE, (DL); 6,6',7,12-Tetramethoxy-2,2'-dimethyl-1beta-berbaman; BRN 0877811; UNII-29EX23D5AJ; Tetrandine; d-Tetrandr; DL-Tetandrine; Tetrandrine CRS; tetrandrine [INN]; NSC 91771; S-(+)-Tetrandrine; Spectrum_000315; Tetrandrine (Standard); (.+-.)-Tetrandrine; SpecPlus_000661; water soluble Tetrandrine; TETRANDRINE [MI]; Prestwick0_000670; Prestwick1_000670; Prestwick2_000670; Prestwick3_000670; Spectrum2_000025; Spectrum3_000659; Spectrum4_000619; Spectrum5_001366; UNII-VS4W77H3SD; CBiol_001914; SCHEMBL20119; BSPBio_000739; BSPBio_001479; BSPBio_002297; KBioGR_000199; KBioGR_001178; KBioSS_000199; KBioSS_000795; TETRANDRINE [WHO-DD]; 2-27-00-00889 (Beilstein Handbook Reference); MLS000728516; DivK1c_006757; SPECTRUM1504185; SPBio_000089; SPBio_002660; BPBio1_000813; CHEMBL176045; orb1224830; orb1304758; orb3139838; SCHEMBL29376018; SCHEMBL30208277; SCHEMBL30581217; GTPL11859; KBio1_001701; KBio2_000199; KBio2_000795; KBio2_002767; KBio2_003363; KBio2_005335; KBio2_005931; KBio3_000397; KBio3_000398; KBio3_001517; BRD8237; DTXSID10178062; DTXSID70881383; WVTKBKWTSCPRNU-KYJUHHDHSA-N; Bio1_000200; Bio1_000689; Bio1_001178; Bio2_000199; Bio2_000679; HMS1361J21; HMS1570E21; HMS1791J21; HMS1989J21; HMS2097E21; HMS2232C06; HMS3402J21; BRD-8237; MSK40306; BDBM50478473; CA-260; CCG-38342; EBC-17168; HSCI1_000014; HY-13764R; STK801908; AKOS004119881; AC-7987; DB14066; FF-0019; FT08803; SDCCGMLS-0066758.P001; IDI1_033949; NCGC00017376-02; NCGC00017376-03; NCGC00017376-04; NCGC00017376-05; NCGC00017376-06; NCGC00017376-10; NCGC00017376-12; NCGC00142549-01; NCGC00142549-02; NCGC00142549-03; NCGC00142549-04; NCGC00182717-01; AS-15343; HY-13764; NCI60_041696; NCI60_042029; ST057602; SY076000; AB00513883; CS-0007782; NS00071807; T2996; C09654; M02568; Q7706612; SR-01000779899-5; SR-01000779899-6; SR-01000779899-7; SR-01000779899-9; Tetrandrine, analytical standard, for drug analysis; (1?)-6,6,7,12-Tetramethoxy-2,2'-dimethylberbaman; BRD-K08078237-001-07-3; BRD-K08078237-001-13-1; BRD-K08078237-001-19-8; (1|?)-6,6,7,12-Tetramethoxy-2,2'-dimethylberbaman; Tetrandrine, European Pharmacopoeia (EP) Reference Standard; Berbaman,6',7,12-tetramethoxy-2,2'-dimethyl-, (1.beta.)-; 6,6',7,12-TETRAMETHOXY-2,2'-DIMETHYL-1-BETA-BERBAMAN; Berbaman, 6,6',7,12-tetramethoxy-2,2'-dimethyl-, (1-beta)-; Berbaman,6',7,12-trtramethoxy-2,2'-dimethyl-, (1.beta.)-(PM)-; (1BETA,1'XI)-6,6',7,12-TETRAMETHOXY-2,2'-DIMETHYLBERBAMAN; Berbaman, 6,6',7,12-trtramethoxy-2,2'-dimethyl-, (1beta)-(+-)-; Berbaman, 6,6',7,12-trtramethoxy-2,2'-dimethyl-, (1beta)-(PM)-; BERBAMAN, 6,6',7,12-TETRAMETHOXY-2,2'-DIMETHYL-, (1.BETA.)-(+/-)-; (1S,14S)-9,20,21,25-tetramethoxy-15,30-dimethyl-7,23-dioxa-15,30-diazaheptacyc lo[22.6.2.2<3,6>.1<8,12>.1<14,18>.0<22,36>.0<27,31>]hexatriaconta-3(33),4,6(34 ),8(35),9,11,18(36),19,21,24,26,31-dodecae; (1S,14S)-9,20,21,25-tetramethoxy-15,30-dimethyl-7,23-dioxa-15,30-diazaheptacyc lo[22.6.2.2<3,6>.1<8,12>.1<14,18>.0<22,36>.0<27,31>]hexatriaconta-3(33),4,6(34 ),8(35),9,11,18(36),19,21,24,26,31-dodecaene; (1S,14S)-9,20,21,25-tetramethoxy-15,30-dimethyl-7,23-dioxa-15,30-diazaheptacyclo[22.6.2.2^{3,6}.1^{8,12}.1^{14,18}.0^{27,31}.0^{22,33}]hexatriaconta-3,5,8,10,12(34),18,20,22(33),24(32),25,27(31),35-dodecaene; 16H-1,24:6,9-DIETHENO-11,15-METHENO-2H-PYRIDO(2',3':17,18)(1,11)DIOXACYCLOEICOSINO(2,3,4-IJ)ISOQUINOLINE, 3,4,4A,5,16A,17,18,19-OCTAHYDRO-12,21,22,26-TETRAMETHOXY-4,17-DIMETHYL-, (4AR,16AR)-REL-; 16H-1,24:6,9-Dietheno-11,15-metheno-2H-pyrido[2',3':17,18][1,11]dioxacycloeicosino[2,3,4-ij]isoquinoline, 3,4,4a,5,16a,17,18,19-octahydro-12,21,22,26-tetramethoxy-4,17-dimethyl-, (4aS,16aS)-; 916770-74-6Synonyme